Different properties of T-cell epitopes within complimentarity- determining regions 1 and 2 of idiotypic VH in B-lymphoma

Scandinavian Journal of Immunology

Volumn 50, Issue 3, 1999, Pages 296-301

  Wen, Y J ^b   Lim, Seah H ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; IMMUNOGLOBULIN HEAVY CHAIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; B CELL LYMPHOMA; COMPLEMENTARITY DETERMINING REGION; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; LYMPHOMA CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN IDIOTYPES; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; INTERFERON TYPE II; LYMPHOMA, B-CELL; MOLECULAR SEQUENCE DATA; PEPTIDES; T-LYMPHOCYTES;

EID: 0032813179     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00599.x     Document Type: Article

References (9)

1. 1 George AJ, Folkard SG, Hamblin TJ, Stevenson FK. Idiotypic vaccination as a treatment for a B cell lymphoma. J Immunol 1988;141:2168-74.
2. 2 Camphell MJ, Essennan L, Byars NE, Allison AC, Levy R. Idiotypic vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. J Immunol 1990;145:1029-36.
3. 3 Campbell MJ, Esserman L, Levy R. Immunotherapy of established murine B cell lymphoma: combination of idiotype immunisation and cyclophosphamide. J Immunol 1988;141:3227-33.
4. 4 Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engelman EG, Levy R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med 1996;2:52-8.
5. 5 Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R. Induction of immune responses in patients with B-cell lymphoma against the surface immunoglobulin idiotype expressed by their tumors. N Engl J Med 1992;327:1209-15.
6. 6 Wen YJ, Lim SH. T cells recognise the VH complementarity-determining region 3 of the idiotypic protein of B cell non-Hodgkin's lymphoma. Eur J Immunol 1997;27:1043-7.
7. 7 Wen YJ, Lim SH. In-vivo immune responses to idiotypic VH complementarity determining region 3 peptide vaccination in B-cell non-Hodgkin's lymphoma. Brit J Haematol 1998;103:663-8.
8. 8 Tomlinson IM, Walter G, Marks JD, Llewellyn MB, Winter GB. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol 1992;227:776-85.
9. 9 Chen J-J, Kaveri S-V, Kohler H. Cryptic T cell epitopes in polymorphic immunoglobulin regions: evidence for positive repertoire selection during fetal development. Eur J Immunol 1992;22:3077-83.